Review of economic benefits of treating chronic hepatitis B with lamivudine.
Lacey
Larry
L
GlaxoSmithKline, Greenford, United Kingdom.
D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D019259:Lamivudine / Q000191:economics* / Q000627:therapeutic use*; D011788:Quality of Life; D018894:Reverse Transcriptase Inhibitors / Q000191:economics* / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine